Quantitation of spinal cord demyelination, remyelination, atrophy, and axonal loss in a model of progressive neurologic injury.
about
Theiler's virus infection: a model for multiple sclerosisAntibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating DiseaseAllelic variation in the Tyk2 and EGF genes as potential genetic determinants of CNS repair.Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosisSpontaneous remyelination following extensive demyelination is associated with improved neurological function in a viral model of multiple sclerosis.Axonopathy is associated with complex axonal transport defects in a model of multiple sclerosis.Differential expression of multiple kallikreins in a viral model of multiple sclerosis points to unique roles in the innate and adaptive immune response.Theiler's virus infection: Pathophysiology of demyelination and neurodegeneration.Axonal pathology and demyelination in viral models of multiple sclerosis.Social disruption induced priming of CNS inflammatory response to Theiler's virus is dependent upon stress induced IL-6 releaseA single dose of a neuron-binding human monoclonal antibody improves brainstem NAA concentrations, a biomarker for density of spinal cord axons, in a model of progressive multiple sclerosis.Absence of perforin expression confers axonal protection despite demyelination.Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis.CD8+ T cells directed against a viral peptide contribute to loss of motor function by disrupting axonal transport in a viral model of fulminant demyelinationHigh-Resolution Diffusion Tensor Spinal Cord MRI Measures as Biomarkers of Disability Progression in a Rodent Model of Progressive Multiple Sclerosis.Semi-automated counting of axon regeneration in poly(lactide co-glycolide) spinal cord bridges.A monoclonal natural human IgM protects axons in the absence of remyelinationThe impact of myelination on axon sparing and locomotor function recovery in spinal cord injury assessed using diffusion tensor imaging.Machine learning approach identifies new pathways associated with demyelination in a viral model of multiple sclerosis.Assessment of hindlimb gait as a powerful indicator of axonal loss in a murine model of progressive CNS demyelination.STAT3 represents a molecular switch possibly inducing astroglial instead of oligodendroglial differentiation of oligodendroglial progenitor cells in Theiler's murine encephalomyelitis.Effect of teriflunomide on cortex-basal ganglia-thalamus (CxBGTh) circuit glutamatergic dysregulation in the Theiler's Murine Encephalomyelitis Virus mouse model of multiple sclerosis.Brain atrophy in picornavirus-infected FVB mice is dependent on the H-2Db class I molecule.Correlation of Brain Atrophy, Disability, and Spinal Cord Atrophy in a Murine Model of Multiple Sclerosis.Impact of Theiler's virus infection on hippocampal neuronal progenitor cells: differential effects in two mouse strains.Extensive injury of descending neurons demonstrated by retrograde labeling in a virus-induced murine model of chronic inflammatory demyelination.Demyelination initiated by oligodendrocyte apoptosis through enhancing endoplasmic reticulum-mitochondria interactions and Id2 expression after compressed spinal cord injury in rats.Understanding the Physiopathology Behind Axial and Radial Diffusivity Changes-What Do We Know?Genetically dominant spinal cord repair in a murine model of chronic progressive multiple sclerosis.
P2860
Q24629115-DE59CFE0-317A-4E3D-B8F3-997C88833DDAQ28080515-DBC34546-B276-4B67-9FEC-4DFBF33808D4Q33640136-4B3A14C7-5085-441E-977A-F8BD77D2710EQ33727379-A20DC04B-FAED-4346-9DFD-D52D5372D445Q33757272-2D5C2C5B-8ED0-480A-943F-C2093FD656CFQ34046204-725F1475-7E67-43FD-B1BB-BF7B956F180AQ34087004-19E15E25-2A6D-4CA7-83E6-69FD5CC2F186Q34118301-9D0F97C8-37AD-4C70-818D-C549B72C7FF2Q35212121-080F31B3-4D7A-42BD-AD4E-EFB8F12714A4Q35489039-53FD17F6-7492-4E8B-988C-3516A7D1CC13Q35564304-7BD91E05-3774-45A3-A01F-A5A868FECB62Q35762252-7B72394B-FCD0-45ED-BCE1-6FD34D4DC624Q35805634-DF826F54-E810-453C-9B1F-59E36AAFEABDQ36003488-D25E340C-AE0C-4BEC-8107-DD0C0DE92F39Q36088855-8F4992EE-3144-441B-AA27-AD719349710BQ36723287-BDECAC93-BF97-467B-88B3-0CE656E60CE3Q36851038-D3758216-986D-452C-ABA2-CCBF558D7B69Q37239354-1AB500F2-DFFB-40F5-8A46-BB724B7F299EQ37335014-03591ECB-A74C-4F9B-BF16-574FEF18B454Q37660487-764FF1A6-3F37-4BDF-A3E5-5B31FA75FD67Q38478956-6BEF911A-EFB2-4DDA-AA39-78CCB15A8FFDQ38630407-5E3A6DB6-8523-4C1D-9F3B-D81E872ADBA6Q40336663-C6D617DF-9BD0-4559-BFBD-B5B08C877F27Q41307793-7E3E1303-5FA6-4D47-97D7-793953EA8B46Q45360064-47B1783F-B41F-4C3F-8EED-E3830B7F26DFQ45740942-0B7BE04F-81F7-4752-ACDE-2736258451E1Q47796994-35CF3278-72B3-4061-B23D-706A9FDC3FF7Q51734164-D28BA2D0-8933-4C40-BAFE-9F9DA40401D1Q55040318-63072342-BC3B-4CCC-B996-42420BBEA893
P2860
Quantitation of spinal cord demyelination, remyelination, atrophy, and axonal loss in a model of progressive neurologic injury.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Quantitation of spinal cord de ...... progressive neurologic injury.
@ast
Quantitation of spinal cord de ...... progressive neurologic injury.
@en
type
label
Quantitation of spinal cord de ...... progressive neurologic injury.
@ast
Quantitation of spinal cord de ...... progressive neurologic injury.
@en
prefLabel
Quantitation of spinal cord de ...... progressive neurologic injury.
@ast
Quantitation of spinal cord de ...... progressive neurologic injury.
@en
P2093
P2860
P1476
Quantitation of spinal cord de ...... progressive neurologic injury.
@en
P2093
D B McGavern
M Rodriguez
P D Murray
P2860
P304
P356
10.1002/(SICI)1097-4547(19991115)58:4<492::AID-JNR3>3.0.CO;2-P
P577
1999-11-01T00:00:00Z